ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Morphic Holding Inc

Morphic Holding Inc (MORF)

55.78
0.03
(0.05%)
Closed July 14 4:00PM
55.78
-0.02
(-0.04%)
After Hours: 4:17PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
55.78
Bid
55.53
Ask
55.94
Volume
5,332,179
55.69 Day's Range 55.84
19.345 52 Week Range 62.08
Market Cap
Previous Close
55.75
Open
55.75
Last Trade Time
Financial Volume
$ 297,321,187
VWAP
55.7598
Average Volume (3m)
1,905,742
Shares Outstanding
50,093,588
Dividend Yield
-
PE Ratio
-18.38
Earnings Per Share (EPS)
-3.04
Revenue
521k
Net Profit
-152.1M

About Morphic Holding Inc

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, inc... Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Morphic Holding Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MORF. The last closing price for Morphic was $55.75. Over the last year, Morphic shares have traded in a share price range of $ 19.345 to $ 62.08.

Morphic currently has 50,093,588 shares outstanding. The market capitalization of Morphic is $2.79 billion. Morphic has a price to earnings ratio (PE ratio) of -18.38.

MORF Latest News

BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News

BP plc (NYSE:BP) – BP expects weak margins in its refining business to impact its second-quarter profits by up to $700 million. The decline in refining margins, due to excess renewable...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
124.0375.685039370131.7555.9931.011614636355.66247912CS
428.52104.62215700727.2655.9925.25520828853.40452784CS
1228.39103.65096750627.3955.9925.25190574249.36898715CS
2627.8299.499284692427.9655.9925.25114011045.60319206CS
52-2.63-4.502653655258.4162.0819.34596574039.08919502CS
156-5.22-8.557377049186168.7519.2353621839.51276453CS
26036.37187.37764039219.41939.937695940.54109366CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.69M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Your Recent History

Delayed Upgrade Clock